Kee Yuan Ngiam, deputy director of the Institute for Digital Medicine (WisDM) at NUS Medicine, and Dean Ho, director of WisDM, map out their plans for CURATE.AI, an AI platform that predicts how a patient is likely to respond to a drug over time.

Read More: Harnessing AI to see a patient’s unique patterns – Nature